News & Currents - Westchester HealthFDA approves Kalydeco to treat rare form of cystic fibrosisJanuary 31, 2012, 10:59 am by FDA News ReleasesThe U.S. Food and Drug Administration today approved Kalydeco (ivacaftor) for the treatment of a rare form of cystic fibrosis (CF) in patients ages 6 years and older who have the specific G551D mutation in the Cystic Fibrosis Transmembrane Regulator (CFTR) gene.
More from FDA News Releases FDA approves generic versions of blood thinner Plavix FDA News Releases: May 17, 2012, 2:04 am The U.S. Food and Drug Administration today approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and stroke by making it less FDA expands use for FilmArray Respiratory Panel FDA News Releases: May 15, 2012, 1:29 am The U.S. Food and Drug Administration today expanded the use for the FilmArray Respiratory Panel, the first test that can simultaneously detect both viral and bacterial causes of respiratory infection from a FDA issues alert on potential dangers of unproven treatment for multiple sclerosis FDA News Releases: May 10, 2012, 8:58 am The U.S. Food and Drug Administration is alerting health care professionals and patients about injuries and death associated with the use of an experimental procedure sometimes called “liberation therapy” or the “liberation FDA proposal aims to help reduce unnecessary radiation exposure for children FDA News Releases: May 9, 2012, 9:00 am Today, the U.S. Food and Drug Administration announced that it is seeking public comment on a proposal encouraging manufacturers to consider the safety of children in the design of new X-ray imaging FDA issues final rule on sterility testing of biological products FDA News Releases: May 3, 2012, 1:52 am The U.S. Food and Drug Administration issued its final rule on sterility testing, amending the requirements for most licensed biological products. |
|
|
